Cargando…
Pluripotent stem cell-induced skeletal muscle progenitor cells with givinostat promote myoangiogenesis and restore dystrophin in injured Duchenne dystrophic muscle
BACKGROUND: Duchenne muscular dystrophy (DMD) is caused by mutations of the gene that encodes the protein dystrophin. A loss of dystrophin leads to severe and progressive muscle wasting in both skeletal and heart muscles. Human induced pluripotent stem cells (hiPSCs) and their derivatives offer impo...
Autores principales: | Xuan, Wanling, Khan, Mahmood, Ashraf, Muhammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881535/ https://www.ncbi.nlm.nih.gov/pubmed/33579366 http://dx.doi.org/10.1186/s13287-021-02174-3 |
Ejemplares similares
-
Dystrophin myonuclear domain restoration governs treatment efficacy in dystrophic muscle
por: Morin, Adrien, et al.
Publicado: (2023) -
miR-106b is a novel target to promote muscle regeneration and restore satellite stem cell function in injured Duchenne dystrophic muscle
por: Rodriguez-Outeiriño, Lara, et al.
Publicado: (2022) -
Induced Pluripotent Stem Cells derived Muscle Progenitors Effectively Mitigate Muscular Dystrophy through Restoring the Dystrophin Distribution
por: Cai, Wen-Feng, et al.
Publicado: (2016) -
Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy
por: He, Ruojie, et al.
Publicado: (2020) -
In vivo genome editing in mouse restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers
por: Chen, Menglong, et al.
Publicado: (2021)